Back to All Events

AI in Drug Development: Turning Breakthroughs into Impact

We are delighted to invite you to our October Dinner & Learn Series, titled “AI in Drug Development: Turning Breakthroughs into Impact.”


This is the second seminar in our Dinner & Learn series, focusing on the practical implementation of AI in preclinical research. The session will feature a keynote presentation and a panel discussion exploring how academia, startups, pharma, and venture capital can collaborate to transform AI-driven discoveries into real-world impact — accelerating the path from innovation to patients.

Location: CIC (Cambridge Innovation Center) – Havana room, 1 Broadway, Cambridge, MA
Date & Time: October 21 (Tue), 2025 | 5:00–9:00 PM

  • 5:00 – 5:50 PM Check-in & Dinner

  • 5:50 – 6:00 PM Opening Remarks (KIST)

  • 6:00 – 7:00 PM Keynote Seminar

  • 7:00 – 8:00 PM Panel Discussion

  • 8:00 – 9:00 PM Networking

Keynote Seminar
Nick (Jun Young) Hong | XtalPi Inc. AI-enabled small molecule drug & target discovery

Panel Discussion

  • Anne Carpenter | Broad Institute of MIT and Harvard

  • Tarun Walia | Novo Nordisk

  • Yang (Claire) Zeng | DoriNano

  • John Keilty | Third Rock Ventures

  • Moderated by Rhie Lim | One Way Ventures

Register Here (Seats Are Limited): https://luma.com/t1e7ytv0

Sponsored by: Korea Institute of Science and Technology (KIST) & One Way Ventures
Co-hosted by: KASBP-Boston Chapter & Kendall On Air

Previous
Previous
September 23

Learning Under Uncertainty: AI Approaches for Accelerating Molecular Design and Discovery